N
Natasha N Pettit
Researcher at University of Chicago
Publications - 64
Citations - 1626
Natasha N Pettit is an academic researcher from University of Chicago. The author has contributed to research in topics: Antimicrobial stewardship & Medicine. The author has an hindex of 16, co-authored 59 publications receiving 1111 citations.
Papers
More filters
Journal ArticleDOI
Quick Sepsis-related Organ Failure Assessment, Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical Deterioration in Infected Patients outside the Intensive Care Unit.
Matthew M. Churpek,Ashley H. Snyder,Xuan Han,Sarah Sokol,Natasha N Pettit,Michael D. Howell,Dana P. Edelson +6 more
TL;DR: Commonly used early warning scores are more accurate than the qSOFA score for predicting death and ICU transfer in non‐ICU patients, and these results suggest that the qsoFA score should not replace general earlywarning scores when risk‐stratifying patients with suspected infection.
Journal ArticleDOI
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
Lucas M. Kimmig,David Wu,Matthew Gold,Natasha N Pettit,David Pitrak,Jeffrey Mueller,Aliya N. Husain,Ece Mutlu,Gökhan M. Mutlu +8 more
TL;DR: Anti-inflammatory therapies such as anti-IL-6 therapy have the potential to impair viral clearance, pre-dispose to secondary infection, and cause harm and this work seeks to raise physician awareness of these issues and highlight the need to better understand the immune response in COVID-19.
Journal ArticleDOI
Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19.
Natasha N Pettit,Erica L. MacKenzie,Jessica P Ridgway,Kenneth Pursell,Daniel Ash,Bhakti K. Patel,Mai T. Pho +6 more
TL;DR: This study sought to determine whether obesity is a risk factor for mortality among patients with COVID‐19.
Journal ArticleDOI
Isavuconazole: A New Option for the Management of Invasive Fungal Infections
Natasha N Pettit,Peggy L. Carver +1 more
TL;DR: Isavuconazole has a broad spectrum of activity and favorable pharmacokinetic properties, providing an advantage over other currently available broad-spectrum azole antifungals and a clinically useful alternative to voriconazole for the treatment of invasive aspergillosis.
Journal ArticleDOI
Documenting Penicillin Allergy: The Impact of Inconsistency.
TL;DR: How allergy documentation affects subsequent antibiotic choice is determined to determine how beta-lactam avoidance and use of other antimicrobial agents, behaviors that may adversely impact care quality and cost are determined.